Back to JPMORGAN CHASE & CO JPMORGAN CHASE & CO

ESPRESPR
7 quarters

Position history for JPMORGAN CHASE & COJPMORGAN CHASE & CO's holdings in ESPERION THERAPEUTICS INC NE

JPMORGAN CHASE & CO holds 1.4M shares of ESPR (ESPERION THERAPEUTICS INC NE), worth $4.4M as of 2026-Q2. The position was increased (+103.7% shares). ESPR represents 0.0% of JPMORGAN CHASE & CO's portfolio.

Current Value

$4.4M

Current Shares

1.4M

Total Value Change

-$999,176

Total Shares Change

-1.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.4M
+103.7%
$4.4M0.0%$3.16
43
2026-Q1
Decreased
685,666
-28.9%
$1.8M0.0%$2.91
0
2025-Q4
Decreased
965,059
-49.0%
$3.6M0.0%$3.69
0
2025-Q3
Increased
1.9M
+236.8%
$5M0.0%$2.64
43
2025-Q2
Decreased
561,396
-70.8%
$552,6380.0%$0.99
0
2025-Q1
Decreased
1.9M
-21.7%
$2.8M0.0%$1.50
0
2024-Q4
New
2.5M
-
$5.4M0.0%$2.15
37

Other major holders of ESPR: BNP PARIBAS FINANCIAL MARKETS, Pentwater Capital Management LP, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used